In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trigemina, Inc.

http://trigemina.com/

Latest From Trigemina, Inc.

Appointments: Nordic Nanovector Loses CEO, Verona Pharma Loses CMO, Plus New CEOs At DalCor And PureTech Health

This week's announcements include two CEO resignations at Nordic Nanovector and Verona Pharma, new CEOs at DalCor Pharmaceuticals and PureTech Health, new CMOs at Medigene, Argenx, Pneuma Respiratory and ReNeuron, plus board appointments.

Executive Changes BioPharmaceutical

Execs On The Move, September 2015

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Recent Financings Of Private Companies, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.

BioPharmaceutical Medical Device

Kumetrix Inc.

Failure to monitor blood glucose regularly to control sugar levels is the leading cause of health complications in diabetics. The primary reason for this failure is the pain involved in the most common method of monitoring -- pricking a fingertip with a lancet to draw a blood sample. While 95% of the $3 billion market for blood glucose monitoring products is held by just four companies, there has been a surge of entrants into the field in recent years. These new players hope to improve patient compliance by developing noninvasive and painless methods for sampling blood or interstitial fluids through the use of implants, spectroscopy, ultrasound, and other innovative techniques. The failure rate among these start-ups is high. And despite the promise of many of these methods, industry analysts agree that an easy to use, cost-effective and reliable alternative to the finger prick is still years away. Kumetrix Inc., a San Francisco-based start-up, believes that it can offer an interim solution with its integrated glucose self-test device, designed to mimic the painless bite of the mosquito.

Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Site Specific
  • Biotechnology
    • Large Molecule
UsernamePublicRestriction

Register